Stocktoria
Tilray Brands, Inc. TLRY
Nasdaq · XNAS · stock · Medicinal Chemicals & Botanical Products · website · IPO 2018-07-19
Tilray Brands, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 29.3% | 28.3% | 23.4% | 18.6% | 24.0% |
| Operating margin | -277.9% | -22.1% | -218.4% | -97.1% | -25.8% |
| Net margin | -266.3% | -31.1% | -231.6% | -75.9% | -71.6% |
| Return on assets | -105.4% | -5.8% | -33.7% | -8.7% | -6.1% |
| Return on equity | -144.7% | -7.1% | -43.6% | -10.7% | -8.2% |
| Debt / equity | — | — | — | 0.04× | 0.05× |
| Current ratio | 2.46 | 2.27 | 1.79 | 2.87 | 2.20 |
| Revenue growth | 4.1% | 25.8% | -0.2% | 22.5% | 143.8% |
Source: SEC EDGAR filings · CIK 0001731348 · as of 2025-05-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.